ライフサイエンスコーパス: mean age

1 tively for 40 implanted eyes in 23 children (mean age 10.2 +/- 5.3 years, range, 1.8-17 years).

2 fasting insulin measured twice in childhood (mean age = 10.5 years at baseline and 15.9 years at foll

3 ly and racially/ethnically diverse children (mean age, 10.3 years; age range, 9.4-11.3 years; 93 fema

4 dren (mean BMI, 26.4; mean BMI z score, 2.0; mean age, 10.4 years; 66.4% girls) and their parent (mea

5 ed in the longitudinal study from childhood (mean age 11.2 years) to early adulthood (mean age 18.2 y

6 familial noncarriers; age range, 1-46 years; mean age, 11.7 years; 31 male participants), and 109 pop

7 17 eyes; 10 male, 2 female) aged 9-14 years (mean age 12.3 years) received ICRS implantation followed

8 as deletion carriers; age range, 1-48 years; mean age, 12.3 years; 42 male patients), 79 carriers of

9 teen adolescents with SCD, aged 10-19 years (mean age 14.9 years), and 5 age-equivalent controls (mea

10 s at eight waves of follow-up, commencing at mean age 15.9 years (SD 0.5; waves 3-6 during adolescenc

11 y, healthy female control adolescents (N=21; mean age, 15.2 years [SD=2.4]) underwent fMRI on two occ

12 ale adolescents with anorexia nervosa (N=21; mean age, 16.4 years [SD=1.9]) underwent functional MRI

13 14.9 years), and 5 age-equivalent controls (mean age 17.4 years).

14 od (mean age 11.2 years) to early adulthood (mean age 18.2 years).

15 rkplace interventions for working-age women (mean age, 18-65 years) in high-income Organization for E

16 f employment in science imply a steady-state mean age 2.3 y higher than the 2008 level of 48.6.

17 203 food-allergic, n=330 non-food-allergic), mean age 2.5 years, with food allergy defined by either

18 A total of 515 eyes of young men (mean age 21.59 +/- 1.15 years) with high myopia (defined

19 Patients were young (mean age, 22 y) and most had received HSCT ( n = 53).

20 the same 38 patients (age range, 1-71 years; mean age, 22 years; 11 women).

21 cardial fibrosis in 25 individuals with SCA (mean age, 23 +/- 13 years) and determine the association

22 duplication carriers; age range, 1-63 years; mean age, 24.8 years; 43 male patients), 64 unaffected f

23 ne (mean age=9.89 years) to young adulthood (mean age=24.40 years).

24 control participants (age range, 6-64 years; mean age, 25.5 years; 64 male participants) were enrolle

25 The sample was predominantly male (84%); mean age = 28.7 years.

26 3 randomized participants who were included (mean age, 28 [SD, 6] years; mean BMI, 39.7 [SD, 7.8]), 3

27 ll, 743630 women were included in the study (mean age, 28.1 [SD, 6.0] years; 41.4% nulliparous).

28 Participants included 371 women (mean age, 28.1 years; Hispanic, 81.6%; mean weight above

29 rdiovascular Conditions) Registry (53% male; mean age 31 [range: 1-86 years]).

30 Of 79 men (mean age 31.5 years) linked to women younger than 40 yea

31 led 40 individuals (17 males and 23 females; mean age 33.30 +/- 9.31 years), 15 with generalized AgP,

32 s of 82 eyes from 46 patients (60.9% female, mean age 33.5 years) were included.

33 The study included 4293 participants (mean age 34, 47% men) from the European Community Respir

34 Thirty-seven healthy controls (25 females, mean age 34.4 years) were also scanned.

35 pants in the laboratory risky decision task (mean age, 34.2 [10.3] years), 44 (59%) were women and 54

36 g adolescence, 6 months apart) and ending at mean age 35.1 years (SD 0.6; wave 10).

37 individuals and consisted of 52.8% females (mean age 35.9 years, SD = 11.9) and 47.2% males (mean ag

38 h repaired tetralogy of Fallot (age >/=16 y; mean age, 35.8+/-10.1 y; 38 male) undergoing PVR were pr

39 2004 and June 2014 in a cohort of 359 women (mean age, 35.9 years +/- 4.8) with uterine fibroids and/

40 age 35.9 years, SD = 11.9) and 47.2% males (mean age = 36.1 years, SD = 10.3).

41 Results Fifty-four patients (34 women [63%]; mean age, 36 years +/- 12 [standard deviation]) were inc

42 ge=86), and 19 certified nursing assistants (mean age=36) in 8 nursing homes.

43 Inclusion of 148 patients (mean age 38.2 +/- 7.1 years) diagnosed with RP, living i

44 obtained from 4 neonates (1 girl and 3 boys; mean age, 38 weeks' postmenstrual age [range, 34-43 week

45 Among the 2 women and 4 men (mean age, 38 years [range, 31-45 years]) who took 10 mg/

46 Sixteen patients (11 women, 5 men; mean age, 39+/-17.2 years) were classified as having def

47 the project underwent 235 scans: 63 pre-BDG (mean age, 4.8+/-1.7 months), 118 BDG (2.9+/-1.4 years),

48 oscopic images from a subset of 30 patients (mean age, 40 years [range, 21-75 years]; 12 men and 18 w

49 al sample of 372 participants [62.6% female, mean age = 41 years (SD = 17 years)].

50 er 2014, 211 patients (77 men and 134 women; mean age, 41.6 years +/- 11.6; range, 24-69 years) with

51 ages of the nevi of a sample of 80 patients (mean age, 42 years [range, 19-80 years]; 33 men and 47 w

52 ials and Methods Adult patients (n = 13 096; mean age, 42 years; age range, 15-95 years) admitted wit

53 .4% girls) and their parent (mean BMI, 31.9; mean age, 42.9 years; 87.3% women; and 31% Hispanic, 49%

54 study population included 3439 individuals, mean age 43 years, 56% women, and 52% black.

55 tudy (2005-2008), a cohort of 393 US adults (mean age 43 years; 47% male), including 114 same-sex sib

56 We included 100 patients (70% female, mean age 43.8+/-9.2 years, mean body mass index 36.9+/-2

57 verweight men (n = 209) and women (n = 710), mean age 44.7 years, body mass index [BMI] 32.4 kg/m(2),

58 No significant differences were found in mean age (44 vs. 39 years; P = 0.121) or gender distribu

59 Among 477 randomized patients (mean age, 44 years [SD, 15]; women, 274 [57%]; median ti

60 nal CHA participants (43% female; 90% white; mean age, 44 years at baseline); 6% had favorable levels

61 ied such relations.We included 52,135 women (mean age: 44.2 y) from the Nurses' Health Study without

62 Among 321 randomized patients (mean age, 45 years [SD, 16.2]; men, 197 [61%]; had exper

63 Of the 501 patients randomized (mean age, 45.9 years; 53.7% men), 395 (78.8%) completed

64 thoracic injuries (men, 74.0% [425 of 574]; mean age, 46.6 years; women, 26.0% [149 of 574]; mean ag

65 th 43 attending at least 1 training session (mean age, 46.7 years; 55.8% male).

66 648 participants (74.4% white, 61.7% female, mean age 47.7 years), 58.0% had definite NASH, 55.5% had

67 Eight patients (mean age 47.8 years) were enrolled in the study (6 femal

68 Among the 398 patients with baseline data (mean age, 47 [SD, 16.0] years; 63% women; 17% smokers; 7

69 ng them, 2812 healthy participants (65% men; mean age, 47.4+/-9.9 years) were eligible for speckle tr

70 ND A total of 10 541 participants (7855 men, mean age: 47.8+/-3.5 years) free of cardiovascular disea

71 Of 164 included subjects (65% men; mean age 48 [18-80] years), CMR contributed to the diagn

72 Among the 158 randomized participants (mean age, 48 years [SD, 13]; 44% women; mean baseline Hb

73 udy period, 2763 (6.6%; 95% CI: 6.3%, 6.8%) (mean age, 48.1 years +/- 18.1; range, 15-102 years) had

74 nts were randomly assigned to the R-E group (mean age, 48.3 years; 72.7% male); a total of 44 partici

75 age, 46.6 years; women, 26.0% [149 of 574]; mean age, 48.9 years).

76 MATERIAL/Twenty-three women (mean age; 48.66+/-12.23 years) with a diagnosis of prima

77 a total of 368 patients with HF (limits for mean age=49-80 years, sex=0%-92% females, left ventricul

78 iography was performed on 3,474 individuals (mean age = 50.2 years) at the CARDIA year 25 examination

79 Of the 570 participants with NAFLD (mean age, 50 years; 54% black; 46% female), 332 (58%) we

80 Among the 136 randomized participants (mean age, 50.4 [SD, 13.3] years; 42% women), 113 (83%) c

81 patients (24 controls, 25 NAFL, and 37 NASH; mean age 51.8 years and body mass index 31.9 kg/m(2) ),

82 in the modified intention-to-treat analysis (mean age, 52 [SD, 14] years; 75 women [35%]).

83 -infected individuals were slightly younger (mean age, 52.5 vs 55.5 years), more likely men (97% vs 9

84 ighteen trials (n = 40058; range, 142-16608; mean age, 53-79 years) were included.

85 Among 1482 randomized GPs (mean age, 53.4 years; 576 women [38.9%]), 1446 participa

86 ancer who were undergoing NST were included (mean age, 54 years; range, 27-84 years).

87 Among 98 randomized participants (mean age, 54.6 years [SD, 8.9]; women, 47 [48%]; mean ba

88 g the study period, a total of 127 patients (mean age 55.3 years, 41.9% females) underwent randomizat

89 al review of 433 oncology patients (203 men; mean age, 55 y), including a total of 1,659 fourth or su

90 esults Thirty study subjects were evaluated (mean age, 55.0 years +/- 8.7 [standard deviation]; 14 me

91 in our analysis (84.1% men; 87.6% Caucasian; mean age, 55.4 +/- 20.1 years; mean body mass index, 27.

92 Of 133 consecutive post AFCA patients (mean age 56.9 +/- 11.8 years, 63.9% male, 69.2% with par

93 We analyzed data from 1791 patients (mean age, 56 +/- 17 years) found to have non-dysplastic

94 btained, 8869 women (age range, 29-85 years; mean age, 56 years) were recruited into the TOMMY trial

95 olled 650 consecutive patients (47.2% women; mean age, 56.1 years +/- 17.7 [standard deviation]).

96 Eighty patients (mean age: 56.0 +/- 8.9 years) with DMt2 were included.

97 ars, 49% males) or coronary CTA (n = 32,961, mean age 57.4 years, 45% males), and were followed for a

98 rwent either functional testing (n = 53,744, mean age 57.4 years, 49% males) or coronary CTA (n = 32,

99 TIPS were placed in all 5529 patients (mean age, 57 years [standard deviation, +/- 10.9 years];

100 Among 160 randomized patients (mean age, 57 years; women, 43%), 156 patients received 1

101 ed retrospective study included 51 patients (mean age, 57.8 years +/- 13.2; range, 13.5-85.8 years) w

102 Forty patients with uveal melanoma (mean age, 57.98+/-14.75 years) were included in this ana

103 traits in 4800 individuals without diabetes (mean age: 57 y; 60% female) from the Malmo Diet and Canc

104 ontally healthy volunteers (HVs) (respective mean ages: 57 +/- 6 and 36 +/- 8 years) were examined.

105 Of 115 patients recruited (73 male; mean age 58 +/- 13 years), there were 41 severe, 35 mode

106 Among 140 randomized patients (mean age, 58 [SD, 8] years, 75 women [54%]), 119 (85%) c

107 ation analyses included 189539 participants (mean age, 58.5 years; 39% women) with 62240 cases of cor

108 Two hundred eighty-three STEMI patients (mean age, 59+/-12 years; 75% male) had cardiac magnetic

109 ve study included 1040 consecutive patients (mean age, 59.5 years +/- 15.8) at four U.S. medical cent

110 cipated; of the 33044 patients of these GPs (mean age, 59.7 years; 17949 women [54.3%]), follow-up at

111 th clinical data obtained from the 77 women (mean age: 59 years) who were examined.

112 Of the 823 children with mean age 6.7 +/- 2.2 years, approximately 10% were refer

113 In 52 males (mean age 60.5 +/- 10.5 years) with first-ever ischaemic

114 ents with and diabetic patients without DPN, mean age (60 years [range, 38-79 years] vs 61 years [ran

115 atory conditions and in 14 control subjects (mean age: 60+/-11 years, mean eGFR: 86+/-16 ml/min per 1

116 istics of the 2 treatment arms were similar (mean age, 61 years; 43% female and 39% black).

117 Twenty-five patients (21 men; mean age, 61 years; range, 30-81 years) with Liver Imagi

118 percutaneous coronary intervention (n=1604; mean age, 61+/-12 years; 75% men) had BMI measured on ad

119 coronary stenting were enrolled, and 11648 (mean age, 61.3 years; 25.1% female) were randomized.

120 s in 14 patients with rectal cancer (11 men [mean age, 61.7 years], three women [mean age, 70.0 years

121 Among the 561 men in the validation cohort (mean age, 62 years; range, 27-86 years), analysis confir

122 ong the 516 men in the developmental cohort (mean age, 62 years; range, 33-85 years) combining testin

123 Among 90 randomized patients (mean age, 62 years; women, 42 [47%]), 58 (64%) received

124 y included 24 patients with prostate cancer (mean age, 63 years) who underwent magnetic resonance (MR

125 Among 3876 IRIS participants (mean age, 63 years; 65% male), 377 stroke events were ob

126 n the symptomatic side (24 men and 13 women; mean age, 63 years; age range, 30-86 years).

127 The cohort included 2550 men (mean age, 63.8 years; 74% white, 55% had intermediate- o

128 Among the 55 patients (23 women and 32 men; mean age, 64 years), the mean follow-up was 6.6 years (r

129 68730 individuals (62275 women and 6455 men; mean age, 64.2 [11.2] years) in the study, during 485322

130 A total of 571 participants (mean age, 64.2 years; standard deviation, 10.9) were fol

131 We collected data on 68,514 women (mean age, 65 +/- 7 years) enrolled in the Nurses' Health

132 Among 1080 elective PCI patients (mean age, 65 years; 74.7% men), 34.0% had DM.

133 rsons with diabetes analyzed for this study (mean age, 65.7 years [95% CI, 64.0-67.3 years]; 51.1% ma

134 ge completion), and older adulthood (income, mean age 66 years) were all dichotomized.

135 udy who underwent angiography were included (mean age = 66 years, median NIH Stroke Scale [NIHSS] = 1

136 -six consecutive patients (68 men, 28 women; mean age, 66 years +/- 9.4) with 100 stage T1a N0M0 biop

137 nalyzable data (57 male, 21 female patients; mean age, 66+/-9 years).

138 d patients, 134 (n=68 LB and 66 RF; 63% men; mean age, 66+10 years) with persistent AF (median AF his

139 D who underwent SPECT between 1991 and 2012 (mean age, 66.2+/-10.9 years; 75.4% men).

140 ipants, 68% were women, and the cohort had a mean age, 66.9 years (SD, 8.4 years).

141 total of 1123 subjects (593 [52.8%] female; mean age, 67.1 years +/- 8.7 [standard deviation]) under

142 cc measurement, and 992 (521 [52.5%] female; mean age, 67.1 years +/- 8.7) underwent FD and T1 measur

143 ons (mean size, 36.9 mm) from 2106 patients (mean age, 67.7 years; 53.2% male).

144 This analysis included 8164 participants (mean age, 67.9 years; 35.3% women; 31.2% blacks) with hy

145 In 147 prostate cancer patients (mean age, 68 y; range, 44-87 y) with prostate-specific a

146 Among 336 randomized patients (mean age, 68 years; 16% women), 333 completed the trial.

147 er eye] and -16.06 +/- 10.22 dB [worse eye]; mean age, 69 +/- 14 years) were analyzed.

148 ses' Health Study since 2000 and 28,989 men (mean age, 69 +/- 8 years) in the Health Professionals Fo

149 Among 10010 patients with subdural hematoma (mean age, 69.2 years; 3462 women [34.6%]), 47.3% were ta

150 METHODS AND Sixty-six PH patients (mean age 7.9+/-4.7 years) were compared with 36 controls

151 d control subjects without diabetes (n = 26; mean age = 7.43 years; 14 females).

152 examined in young children with T1D (n = 57; mean age = 7.88 years; 27 females) as compared with age-

153 434 children with asthma who consented, 286 (mean age, 7.7 yr; male sex, 65.8%) were mite sensitized,

154 ound to be most common in older individuals (mean age, 70 years) and men (n = 42 of 55; 76%).

155 (11 men [mean age, 61.7 years], three women [mean age, 70.0 years]) were analyzed to extract (a) glob

156 Between May and December 2015, 10 patients (mean age, 70.4 years; range, 58-82 years) with biochemic

157 In 1 eye of 200 consecutive patients (mean age 71 +/- 9 years) with cataract, a Pentacam HR (O

158 Spouses of patients with HF were elderly (mean age, 71 years), often had comorbid conditions, and

159 distant metastases and progressive disease (mean age, 71.4 y).

160 207 consecutive patients (131 men, 76 women; mean age, 71.9 years +/- 10.9) with 217 biopsy-proven re

161 (1991-1995) in a cohort of 1182 Swedish men (mean age: 71 y).

162 Among the 493 men with AAMI (mean age, 72.3 years [SD, 5.8]; mean baseline testostero

163 A total of 305 patients (mean age 73 +/- 11 years; 75% male) were included.

164 Fifteen eyes (15 patients, mean age 73 +/- 13 years) were included.

165 isk of FI among 55,828 postmenopausal women (mean age, 73 years) who participated in the Nurses' Heal

166 A CT study set of 150 patients (mean age, 73 years; age range, 55-96 years; 92 women, 58

167 Among 383 randomized patients (mean age, 73.9 years; 38.4% women; 368 [96.1%] completed

168 tients with nonvalvular atrial fibrillation (mean age, 74.7 years [SD, 10.8]; men, 55.8%; NOAC dabiga

169 in 1,908 patients with acute HF (1,186 male; mean age 75.66 +/- 11.74 years).

170 rst presentation of heart failure increased (mean age 76.5 years [SD 12.0] to 77.0 years [12.9], adju

171 We included 64 consecutive patients (mean age 76.6+/-10 years) deemed unsuitable for surgery

172 and fully executed for 22 patients (31.4%) (mean age, 76 years [interquartile range, 59-86 years]; 1

173 Risk in Communities; age range, 67-90 years; mean age, 76+/-5 years; 42% male; 21% black), we determi

174 Responses from 113 participants (mean age, 76.2+/-9.3 years; 58.4% were female) and 113 s

175 partially executed for 48 patients (68.6%) (mean age, 77 years [interquartile range, 65-84 years]; 2

176 A total of 305 patients (mean age, 79+/-9 years; 44% men; Society of Thoracic Sur

177 , 953 consented to participate in the study (mean age, 86 years; 76% female) and 359 had 840 falls in

178 sample included 15 residents with dementia (mean age=86), and 19 certified nursing assistants (mean

179 ic imaging on 14 pairs of monozygotic twins (mean age 9.7, s.d. 1.9 years), we found that discordance

180 dred nineteen children 2 to 16 years of age (mean age, 9.4 years; standard deviation [SD], 4.56 years

181 eight assessments from comparison baseline (mean age=9.89 years) to young adulthood (mean age=24.40

182 d old individuals from fish stocks, reducing mean age and age diversity among spawners.

183 We here show that high mean age and size in the spawning stock of Barents Sea c

184 466 901 men and women (mean age at baseline 56.5 years [SD 8.1]) were included

185 The mean age at diagnosis was 28.3 years and 60.6% of diagno

186 Mean age at diagnosis was 46 years.

187 Among 23603 survivors of childhood cancer (mean age at diagnosis, 7.7 years; 46% female) the most c

188 Among respondents, mean age at donation was 43.6 +/- 10.6 years, 64% were w

189 The mean age at enrollment was 68.6+/-9.6 years.

190 Among 329 participants, the mean age at evaluation was 27.6 years, with a 21-year me

191 347 infants (95%) with primary outcome data (mean age at follow-up, 20.7 [SD, 3.5] months; 42% female

192 ale and 23 [52%] female) aged 2 to 18 years (mean age at initial presentation, 28 months; range, 0-12

193 Mean age at presentation was 32 years, with a 3:2 male-t

194 Mean age at presentation was 41.8 (range 3.3-81.6) years

195 of 179] from online survey; 85 [60%] female; mean age at start of study, 53 [range, 8-83] years; 131

196 The mean age at the age 5 years follow-up visit was 5.0 +/-

197 ts were female; 33 (73%) were white; and the mean age at the time of laser treatment was 14.5 years (

198 enty-nine consecutive adult patients, with a mean age at transplant of 24 years (range, 17-50 years),

199 easurements, CD/UC 84/28, male/female 50/62, mean age CD/UC: 36/35 years) were enrolled in this conse

200 From 1995 to 2015, mean age decreased from 66+/-14 to 63+/-14 years in pati

201 Mean age for the cohort was 62.4 years (standard deviati

202 een these groups, significant differences in mean age, gender distributions, and mean baseline VA wer

203 The mean age in the case series was 61.2+/-14.9 years.

204 8.3 years (3.9 million person-years) with a mean age of 21 years, 6,999 first suicide attempts and 7

205 eropositive cases was 1 to 78 years with the mean age of 27 years.

206 otal of 17 subjects (10 men, 7 women) with a mean age of 31.2 years (range, 17-69 year) and anisometr

207 Patients had a mean age of 34 years (SD 8) and average illness duration

208 The study populations had a mean age of 35-53 years, 59-69% were female, and had a m

209 eated thyrotoxicosis (25 female and 12 male; mean age of 44 years) and 15 ageand sex-matched controls

210 hty-one studies (4233 patients, 59.1% women, mean age of 46 years) were included.

211 tients with lymphomas (45 females, 70 males; mean age of 46 years).

212 ypothetical cohorts of 1,000 patients with a mean age of 50 over a 30-year time horizon from a third-

213 eijing, Hubei and Guangdong in patients with mean age of 53.9 years, and acute (70%) or chronic (30%)

214 A total of 19,460 patients with a mean age of 54 +/- 17 years were included.

215 mple contained 1 738 886 participants with a mean age of 55.6 years (SD 9.7), 59.5% of whom were wome

216 TwinsUK cohort in the United Kingdom, with a mean age of 57 years (range, 17-82 years).

217 Patients had a mean age of 58 years, body mass index of 28 kg/m, 77% ha

218 nd 550 were African-American (60.7%), with a mean age of 58.7 years.

219 of whom 48% were women and 50% had diabetes (mean age of 60 years old, mean eGFR =38 ml/min per 1.73

220 Forty-six patients, with a mean age of 62 +/- 8 years, a median duration since time

221 The ICC patients had a mean age of 63.8+/-11.6 years and 63% were males.

222 The mean age of 634 patients was 80 years.

223 ents with a previous revascularization had a mean age of 66 years, 73% were male, and the median base

224 1% Chinese, 14% Hispanic, and 52% men with a mean age of 67.6 years) at 6 sites had both serum NT-pro

225 patients were diagnosed with cataract with a mean age of 68.8+/-10.3 years and 374 (62.3%) were femal

226 ants, 4496 (2028 men and 2468 women), with a mean age of 73 years, provided a blood sample; 2137 had

227 The 705 participants were 58% female with a mean age of 77 (SD, 7.1) years.

228 The 4,062 matched patients had a mean age of 79 +/- 10 years, 66% were women, and 10% wer

229 Mean age of disease onset was 49.7+/-12.3 years (mean+/-

230 The mean age of our cohort was 54 years, with 61% females, a

231 Mean age of participants was 58 years (SD 11) and mean b

232 The mean age of participants was 65.9 years (SD 8.3) and 297

233 The mean age of participants was 69 years, 76% of participan

234 The mean age of patients at the first visit was 57.9+/-13.4

235 The mean age of patients was 73.5 +/- 8.2 years, and 43.0% w

236 The mean age of patients when they underwent genetic testing

237 Over time, the mean age of recipients increased and more marginal organ

238 The mean age of study participants was approximately 24 year

239 Results The mean age of the 1669 participants was 67.4 years +/- 8.7

240 cts, 21 were males and 9 were females with a mean age of the 50.25 +/- 7.80 years (range 33-66 years)

241 The mean age of the BDD cohort was 48.7 years, 95% were whit

242 At baseline, the mean age of the cohort was 17.1 years (SD 1.7) and mean

243 Mean age of the cohort was 72 years; 57% were women, and

244 , 2.64; P = .008), despite the fact that the mean age of the MESA cohort was 17 years greater than th

245 The mean age of the participants was 35.8 years, and 68.3% w

246 The mean age of the patients was 56.6 years (range, 28-86).

247 Mean age of the patients was 60.7 years (standard deviat

248 The mean age of the subjects is 42.5 +/- 16.0 years, the mea

249 edical mimics and 45.5% stroke, and younger (mean age (SD)) 49.1 (18.8) than medical mimic (63.5 year

250 t lean normal subjects (10 women and 10 men; mean age +/- SD, 23.3 +/- 3.8 y; body mass index, 23.7 +

251 ective study, 41 patients (16 women, 25 men; mean age +/- SD, 48 +/- 14 y) with cerebral gliomas (Wor

252 reduction of (18)F-FDG doses of 19 patients (mean age +/- SD, 50.9 +/- 11.7 y; mean body mass index +

253 d data on 77 patients consecutively treated (mean age +/- SD, 66.4 +/- 12.2 y) for uHCC (36 uninodula

254 ive patients with mild cognitive impairment (mean age +/- SD, 72.69 +/- 6.54 y; 29 men/16 women) who

255 were 67% male, 84% non-Hispanic white, with mean age+/-SD 62+/-11 years; 16% (n=237) were cognitivel

256 Results In 4347 patients (51.8% women; mean age +/- standard deviation, 60.4 years +/- 8.2), co

257 whole-spine MR imaging examinations (63 men; mean age +/- standard deviation, 61.4 years +/- 11.8) pe

258 Twenty-three women (mean age +/- standard deviation, 61.7 years +/- 13.8) we

259 Two hundred fifty-six patients (143 women; mean age +/- standard deviation, 63 years +/- 17) with n

260 Mean age was 11.1 years +/- 4.7 [standard deviation] in

261 The mean age was 26.0 years.

262 nts, 35% were women, 35% were white, and the mean age was 27.6 years.

263 nged from nine months to five years, and the mean age was 34.5 months.

264 Mean age was 41 years, 70% were females, and median time

265 the second analysis, 855 (34.0%) were male; mean age was 42.65 (12.17) years.

266 ss index of all patients was 44 +/- 11 kg/m, mean age was 43 +/- 5.3 years, and 72% of patients were

267 cipants, 57% were women, and 57% were black; mean age was 48 years, and mean SBP/diastolic BP was 135

268 Participants' (n = 147) mean age was 49 years, 76% were white, 12% were Hispanic

269 Among the 122 patients in the study, the mean age was 53 years (range, 28-77 years); 77.0% were w

270 Group 2 comprised 22 eyes from 20 patients; mean age was 53.3 +/- 13.6 years (range = 30-69); 63.6%

271 Mean age was 54 (interquartile range [IQR], 47-64) years

272 eGFR >/=60 ml/min per 1.73 m(2) At baseline, mean age was 55 years old, 37% of participants were men,

273 Surrogates' mean age was 55.5 (SD, 11.8), and they were making decis

274 this cohort, 536 (82.7%) were female and the mean age was 55.8 years (standard deviation, 15.6 years)

275 leted the protocol; 22 were men (47.8%), and mean age was 56.30 +/- 10.63 years.

276 Mean age was 57.3+/-9.2 years, mean LA size was 4.9+/-1.

277 The mean age was 58 years, half of the patients were men, ha

278 tients in this study, 321 (96.7%) were male, mean age was 58.4 years, and mean (SD) time of follow-up

279 Mean age was 62+/-13 years, and 31% were male.

280 In our cohort, the mean age was 63+/-13 years, 70% were female, 78% had hyp

281 Overall, mean age was 63.4 years, 32.5% had diabetes mellitus, an

282 At baseline, the groups were well matched; mean age was 64 years, 75% were male, mean left ventricu

283 The mean age was 65 years, and 642 composite events took pla

284 Mean age was 65+/-14 years and 63% were male.

285 At baseline, the mean age was 65.0 years, the mean duration of diabetes w

286 Mean age was 65.3 years, and 61% were women.

287 Of these, 3371 (76.7%) were men; pooled mean age was 65.4 years.

288 Mean age was 67.5 +/- 11.5 years (50.1% male, 49.9% fema

289 Across all visits, mean age was 69.2 years, 51.8% were female, and 56.6% we

290 Mean age was 70 years (SD 11.77).

291 2003 patients with known weight and height, mean age was 70+/-12 years and 67% were men.

292 Mean age was 70+/-9 years, and 50% were female.

293 Mean age was 70.4 years (+/-9.6 standard deviation [SD])

294 The mean age was 71 years, mean FEV1 was 1.3 L, and 59% had

295 The mean age was 75 years at the time of implantation; 25.3%

296 Mean age was 77.7 years (SD 9.7) and 173 (68%) of 253 pa

297 om 1494 GWTG-Stroke hospitals were included; mean age was 80 years, 59% female, and 19% nonwhite.

298 Mean age was 81.8 +/- 6.2 years, 64.9% were women, the m

299 3 RCTs, DME: 9, RVO: 5), the OCEAN patients' mean age was significantly higher in every indication.

300 The mean ages were 54.9 years and 55.4 years for the eravacy